ExLibris header image
SFX Logo
Title: Half of rifampicin-resistant Mycobacterium tuberculosis complex isolated from tuberculosis patients in Sub-Saharan Africa have concomitant resistance to pyrazinamide
Source:

Plos One [1932-6203] Ngabonziza, Jean Claude Semuto yr:2017


Collapse list of basic services Basic
Full text
Full text available via PubMed Central
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. "Molecular mechanisms of action, resistance, detection to the first-line anti tuberculosis drugs: Rifampicin and pyrazinamide in the post whole genome sequencing era." Tuberculosis 105: 96-107. Link to SFX for this item
2. "Re-expansion pulmonary oedema." The lancet 392.10146: 507-507. Link to SFX for this item
3. "DNA-DEPENDENT SYNTHESIS OF RNA BY Escherichia coli RNA POLYMERASE: RELEASE AND REINITIATION OF RNA CHAINS FROM DNA TEMPLATES." Proceedings of the National Academy of Sciences of the United States of America. 64.2: 779-786. Link to SFX for this item
4. Ranjan, A. "Evaluation of codon bias perspectives in phage therapy of Mycobacterium tuberculosis by multivariate analysis." In Silico Biology 7.4-5 (2007): 423-31. Link to SFX for this item
5. Traore, H. "Low-cost rapid detection of rifampicin resistant tuberculosis using bacteriophage in Kampala, Uganda." Annals of clinical microbiology and antimicrobials 6.1 (2007): 1-1. Link to Full Text for this item Link to SFX for this item
6. Rubio, M. "Cost-effective control of drug-resistant TB: listening to other voices." PLoS medicine 3.12 (2007). Link to Full Text for this item Link to SFX for this item
7. Broxmeyer, L. "Killing of Mycobacterium avium and Mycobacterium tuberculosis by a mycobacteriophage delivered by a nonvirulent mycobacterium: a model for phage therapy of intracellular bacterial pathogens." The journal of infectious diseases 186.8 (2002): 1155-60. Link to Full Text for this item Link to SFX for this item
8. Yates, D. "Targeting transport in CNS oedema." Nature reviews. 21.7: 350-351. Link to SFX for this item
9. "The prognosis model of treatment efficiency for pulmonary tuberculosis in intensive phase of antituberculosis therapy." ScienceRise: Medical Science 7 (27): 27-32. Link to SFX for this item
10. "Action Mechanism of Antitubercular Isoniazid." Journal of biological chemistry. 275.4: 2520-2526. Link to SFX for this item
11. Carrigy, Nicholas B. "Anti-Tuberculosis Bacteriophage D29 Delivery with a Vibrating Mesh Nebulizer, Jet Nebulizer, and Soft Mist Inhaler." Pharmaceutical research 34.10: 2084-2096. Link to SFX for this item
12. Sasovetz, S. "26-Year-Old Man With Shortness of Breath After Open Ocean Swim." Military Medicine 180.12 (2015): 1207-1208. Link to SFX for this item
13. Luis Soto-Hernandez, J. L. Journal of the neurological sciences 357.s1 (2015). Link to SFX for this item
14. Kutateladze, M. "Bacteriophages as potential new therapeutics to replace or supplement antibiotics." Trends in biotechnology 28.12 (2010): 591-595. Link to SFX for this item
15. Naidoo, P. "Costs of measures to control tuberculosis/HIV in public primary care facilities in Cape Town, South Africa." Bulletin of the World Health Organization 84.7 (2006): 528-36. Link to Full Text for this item Link to SFX for this item
16. Fukuda, R. "Mechanism of the rifampicin induction of rna polymerase beta and beta' subunit synthesis in escherichia-coli." The Journal of biological chemistry 258.4 (1983): 2720-8. Link to SFX for this item
17. Karlin, S. "Predicted highly expressed genes of diverse prokaryotic genomes." Journal of bacteriology 182.18 (2000): 5238-5250. Link to Full Text for this item Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced